Action mechanism of quercetin as AGE inhibitor
synthesized by sol–gel method.
011;60:41–47.
9
J
Sol–Gel Sci Technol.
References
2
[
1] Benavente-García O, Castillo J. Update on uses and properties
of citrus flavonoids: new findings in anticancer, cardiovascular,
and anti-inflammatory activity. J Agric Food Chem. 2008;56:
[23] Di Costanzo L, Flores LV, Christianson DW. Stereochemistry of
guanidine-metal interactions: Implications for L-arginine-metal
interactions in protein structure and function. Proteins. 2006;65:
637–642.
6185–6205.
[
[
[
[
[
[
[
[
2] Matsuura N, Aradate T, Sasaki C, et al. Screening system for
the Maillard reaction inhibitor from natural product extracts. J
Health Sci. 2002;48:520–526.
3] Matsuda H, Morikawa T, Ando S, et al. Structural requirements
of flavonoids for nitric oxide production inhibitory activity and
mechanism of action. Bioorg Med Chem. 2003;11:1995–2000.
4] Wu CH, Yen G. Inhibitory effect of naturally occurring flavo-
noids on the formation of advanced glycation endproducts. J
Agric Food Chem. 2005;53:3167–3173.
5] Sang S, Shao X, Bai N, et al. Tea polyphenol (−)-epigallocate-
chin-3-gallate: a new trapping agent of reactive dicarbonyl spe-
cies. Chem Res Toxicol. 2007;20:1862–1870.
6] Shao X, Bai N, He K, et al. Apple polyphenols, phloretin and
phloridzin: new trapping agents of reactive dicarbonyl species.
Chem Res Toxicol. 2008;21:2042–2050.
7] Lv L, Shao X, Chen H, et al. Genistein inhibits advanced glyca-
tion end product formation by trapping methylglyoxal. Chem
Res Toxicol. 2011;24:579–586.
8] Li D, Mitsuhashi S, Ubukata M. Protective effects of hesperidin
derivatives and their stereoisomers against advanced glycation
end-products formation. Pharm Biol. 2012;50:1531–1535.
9] Li D, Shigetomi K, Mitsuhashi S, et al. Maillard reaction inhibi-
tors produced by Paecilomyces sp. Biosci Biotechnol Biochem.
[24] Gold MH, Youngs HL, Sollewijn G, et al. In: Sigel A, Sigel H,
editors. Metal ions in biological systems: manganese and its role
in biological processes. Vol. 37, New York (NY): Marcel
Dekker, Inc; 2000. p. 559–586.
[25] Shamsi FA, Partal A, Sady C, et al. Immunological evidence for
methylglyoxal-derived modifications in vivo. Determination of
antigenic epitopes. J Biol Chem. 1998;273:6928–6936.
[26] Beisswenger P, Howell S, Nelson R, et al. α-Oxoaldehyde meta-
bolism and diabetic complications. Biochem Soc Trans. 2003;31:
1358–1363.
[27] Kilhovd BK, Juutilainen A, Lehto S, et al. Increased serum
levels of methylglyoxal-derived hydroimidazolone-AGE are
associated with increased cardiovascular disease mortality in
nondiabetic women. Atherosclerosis. 2009;205:590–594.
[28] Thomas M, Baynes J, Thorpe S, et al. The role of AGEs and
AGE inhibitors in diabetic cardiovascular disease. Curr Drug
Targets. 2005;6:453–474.
[29] Cervantes-Laurean D, Schramm DD, Jacobson EL, et al. Inhibi-
tion of advanced glycation end product formation on collagen by
rutin and its metabolites. J Nutr Biochem. 2006;17:531–540.
[30] Inai M, Miura Y, Honda S, et al. Metmyoglobin reduction by
polyphenols and mechanism of the conversion of metmyoglobin
to oxymyoglobin by quercetin. J Agric Food Chem. 2014;62:
893–901.
2013;77:2499–2501.
[
10] Li XL, Zheng T, Sang S, et al. Quercetin inhibits advanced
glycation end product formation by trapping methylglyoxal and
glyoxal. J Agric Food Chem. 2014;62:12152–12158.
[31] Nagamatsu R, Mitsuhashi S, Shigetomi K, et al. Cleavage of
α-dicarbonyl compounds by terpene hydroperoxide. Biosci
Biotechnol Biochem. 2012;76:1904–1908.
[
11] Matsuura N, Aradate T, Kurosaka C, et al. 2014. Potent protein
glycation inhibition of plantagoside in Plantago major seeds.
12] Shao X, Chen H, Zhu Y, et al. Essential structural requirements
and additive effects for flavonoids to scavenge methylglyoxal. J
Agric Food Chem. 2014;62:3202–3210.
[32] Kasprzak MM, Erxleben A, Ochocki J. Properties and
applications of flavonoid metal complexes. RSC Adv. 2015;5:
45853–45877.
[33] Peyroux J, Sternberg M. Advanced glycation endproducts
(AGEs): pharmacological inhibition in diabetes. Pathol Biol.
2006;54:405–419.
[34] Aguirre L, Arias N, Macarulla MT, et al. Beneficial effects of
quercetin on obesity and diabetes. Open Nutraceuticals J. 2011;
4:189–198.
[35] Thomas MC, Baynes JW, Thorpe SR, et al. The role of AGEs
and AGE inhibitors in diabetic cardiovascular disease. Curr Drug
Targets. 2005;6:453–474.
[36] Webster J, Urban C, Berbaum K, et al. The carbonyl scavengers
aminoguanidine and tenilsetam protect against the neurotoxic
effects of methylglyoxal. Neurotoxic Res. 2005;7:95–101.
[37] Price DL, Rhett PM, Thorpe SR, et al. Chelating activity of
advanced glycation end-product inhibitors. J Biol Chem. 2001;
276:48967–48972.
[38] Beisswenger P, Ruggiero-Lopez D. Metformin inhibition of
glycation processes. Diabetes Metab. 2003;29:6S95–6S103.
[39] Beisswenger PJ, Howell SK, Touchette AD, et al. Metformin
[
[
[
[
[
[
[
[
[
[
[
13] Yoon SR, Shim SM. Inhibitory effect of polyphenols in Houttuy-
nia cordata on advanced glycation end-products (AGEs) by trap-
ping methylglyoxal. LWT-Food Sci Technol. 2014;61:158–163.
14] Lo CY, Li S, Tan D, et al. Trapping reactions of reactive car-
bonyl species with tea polyphenols in simulated physiological
conditions. Mol Nutr Food Res. 2006;50:1118–1128.
15] Mira L, Fernadez MT, Santos M, et al. Interactions of flavonoids
with iron and copper ions: a mechanism for their antioxidant
activity. Free Radical Res. 2002;36:1199–1208.
16] Zhang W, Chen C, Shi H, et al. Curcumin is a biologically
active copper chelator with antitumor activity. Phytomedicine.
2016;23:1–8.
17] Vistoli G, De Maddis D, Cipak A, et al. Advanced glycoxidation
and lipoxidation end products (AGEs and ALEs): an overview of
their mechanisms of formation. Free Radical Res. 2013;47:3–27.
18] Han C, Lu Y, Wei Y, et al. D-ribose induces cellular protein
glycation and impairs mouse spatial cognition. PLoS One.
reduces systemic methylglyoxal levels in type
2 diabetes.
Diabetes. 1999;48:198–202.
[40] Nagaraj RH. Effect of pyridoxamine on chemical modification
of proteins by carbonyls in diabetic rats: characterization of a
major product from the reaction of pyridoxamine and methylgly-
oxal. Arch Biochem Biophys. 2002;402:110–119.
[41] Voziyan PA, Metz TO, Baynes JW, et al. A post-amadori inhibi-
tor pyridoxamine also inhibits chemical modification of proteins
by scavenging carbonyl intermediates of carbohydrate and lipid
degradation. J Biol Chem. 2002;277:3397–3403.
[42] Reddy VP, Zhu X, Perry G, et al. Oxidative stress in diabetes
and Alzheimer’s disease. J Alzheimers Dis. 2009;16:763–774.
[43] Jahan H, Choudhary MI. Glycation, carbonyl stress and AGEs
inhibitors: a patent review. Expert Opin Ther Pat. 2015;25:
1267–1284.
2011;6:e24623.
19] Ghosh S, Pandey NK, Roy AS, et al. Prolonged glycation of
hen egg white lysozyme generates non amyloidal structures.
PLoS One. 2013;8:e74336.
20] Luckey TD, Venugopal B. Metal toxicity in mammals. Vol. 1,
Physiologic and chemical basis for metal toxicity. New York
(
NY): Springer; 1977.
21] Symons MCR, Benbow JA, Pelmore H. Study of calcium ion bind-
ing to D-ribose in aqueous solutions using hydroxy-proton reso-
nance shifts. J Chem Soc Faraday Trans 1. 1982;78:3671–3677.
22] Ye Y, Liu Q, Wang J. Influence of saccharides chelating agent
2
on particle size and magnetic properties of Co Z hexaferrite